Severe COVID-19 frequently progresses to ARDS, characterized by severe alveolar edema, diffuse inflammation, and elevated markers such as CRP and erythrocyte sedimentation rate (Huang et al., 2020; Zhou et al., 2020). The gene discussed is CRP; the disease is COVID-19.